DMPK for Monoclonal Antibodies: An Introduction to the Core Concepts

Capabilities
Recorded: October 2026
About our DMPK Webinar on Monoclonal Antibodies
Monoclonal antibodies (mAbs) have transformed the treatment landscape for a wide range of diseases and continue to play an increasingly important role in drug discovery and development. Unlike small molecule drugs, mAbs possess unique structural and pharmacokinetic properties that require specialized approaches to development. Join experts from Pharmaron to gain a practical understanding of mAb biology, pharmacokinetics, and disposition, and discover key considerations for advancing antibody-based therapeutics with confidence.
What do you need to know to advance monoclonal antibody therapeutics with confidence?
In this session, Michael Bestwickprovides an introduction to monoclonal antibodies, exploring what they are, how they are produced, and how they differ from traditional small molecule therapeutics. The webinar examines the ADME properties of mAbs, including routes of administration, absorption and distribution mechanisms, elimination pathways, and the role of neonatal Fc receptor (FcRn) biology in regulating antibody half-life.
The session also covers target-mediated drug disposition (TMDD) and its impact on mAb pharmacokinetics, highlighting important considerations for chronic dosing strategies and the potential effects of anti-drug antibodies (ADAs). Attendees will gain a clearer understanding of current best practices, emerging trends in the field, and the key factors influencing the successful development of monoclonal antibody therapeutics.
What You’ll Learn
In this webinar you will learn:
- mAbs play a significant part in the treatment of many diseases
- They have a number of key considerations based on their properties and size
- Dose route and frequency
- Identification of target exposure considering TMDD
- Chronic dosing is important to understand
- Formation of Anti-Drug Antibodies (ADAs)
- Depletion of target altered pharmacokinetics
Register now to watch the on-demand webinar and gain practical insights into monoclonal antibody drug development.